Motley Fool Asset Management LLC - ULTRAGENYX PHARMACEUTICAL IN ownership

ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 219 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q3 2023. The put-call ratio across all filers is 0.74 and the average weighting 0.2%.

Quarter-by-quarter ownership
Motley Fool Asset Management LLC ownership history of ULTRAGENYX PHARMACEUTICAL IN
ValueSharesWeighting
Q3 2023$5,565,108
+31.6%
156,104
+70.3%
0.45%
+18.9%
Q2 2023$4,229,567
+204.9%
91,688
+165.1%
0.38%
+145.8%
Q1 2023$1,387,099
-19.0%
34,591
-6.4%
0.15%
-20.7%
Q4 2022$1,712,496
+3.1%
36,963
-7.9%
0.19%
+18.4%
Q3 2022$1,661,000
-68.3%
40,114
-51.2%
0.16%
-67.0%
Q2 2022$5,245,000
-17.8%
82,206
-6.4%
0.49%
+5.6%
Q1 2022$6,379,000
-36.8%
87,837
-26.8%
0.47%
-27.4%
Q4 2021$10,090,000
-16.7%
119,993
-10.7%
0.64%
-18.0%
Q3 2021$12,118,000
-25.7%
134,357
-21.4%
0.79%
-26.9%
Q2 2021$16,304,000
-6.0%
170,996
+12.3%
1.08%
-13.8%
Q1 2021$17,344,000
+126.4%
152,326
+175.3%
1.25%
+118.5%
Q4 2020$7,660,000
+97.1%
55,336
+22.0%
0.57%
+65.8%
Q3 2020$3,887,000
+17.3%
45,346
+7.1%
0.34%
+3.9%
Q2 2020$3,313,000
+159.2%
42,349
+47.2%
0.33%
+100.0%
Q1 2020$1,278,00028,7650.17%
Other shareholders
ULTRAGENYX PHARMACEUTICAL IN shareholders Q3 2023
NameSharesValueWeighting ↓
EcoR1 Capital, LLC 497,899$31,617,0003.20%
HIGHLINE CAPITAL MANAGEMENT, L.P. 390,453$24,794,0001.81%
First Light Asset Management, LLC 180,017$11,431,0001.59%
Rock Springs Capital Management LP 580,000$36,830,0001.33%
Capital Impact Advisors, LLC 36,165$2,244,0000.82%
SECTOR GAMMA AS 79,653$5,058,0000.81%
Verity Asset Management, Inc. 7,193$457,0000.51%
Opus Point Partners Management, LLC 5,064$322,0000.48%
Capital International Sarl 52,000$3,302,0000.46%
PACIFIC VIEW ASSET MANAGEMENT, LLC 6,216$394,0000.43%
View complete list of ULTRAGENYX PHARMACEUTICAL IN shareholders